Synovus Financial’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-900
Closed -$203K 879
2023
Q3
$203K Buy
+900
New +$203K ﹤0.01% 803
2023
Q2
Sell
-900
Closed -$202K 858
2023
Q1
$202K Hold
900
﹤0.01% 789
2022
Q4
$250K Buy
+900
New +$250K ﹤0.01% 763
2022
Q3
Sell
-900
Closed -$212K 882
2022
Q2
$212K Buy
+900
New +$212K ﹤0.01% 795
2021
Q4
Sell
-1,100
Closed -$203K 887
2021
Q3
$203K Buy
+1,100
New +$203K ﹤0.01% 807
2020
Q3
Sell
-1,100
Closed -$133K 1419
2020
Q2
$133K Hold
1,100
﹤0.01% 726
2020
Q1
$104K Hold
1,100
﹤0.01% 918
2019
Q4
$97K Hold
1,100
﹤0.01% 813
2019
Q3
$88K Sell
1,100
-109
-9% -$8.72K ﹤0.01% 799
2019
Q2
$95K Sell
1,209
-2,545
-68% -$200K ﹤0.01% 714
2019
Q1
$442K Sell
3,754
-833
-18% -$98.1K 0.01% 465
2018
Q4
$498K Sell
4,587
-955
-17% -$104K 0.01% 424
2018
Q3
$711K Sell
5,542
-38
-0.7% -$4.88K 0.01% 397
2018
Q2
$627K Sell
5,580
-83
-1% -$9.33K 0.01% 404
2018
Q1
$634K Buy
5,663
+48
+0.9% +$5.37K 0.01% 402
2017
Q4
$829K Sell
5,615
-119
-2% -$17.6K 0.01% 329
2017
Q3
$673K Buy
5,734
+95
+2% +$11.2K 0.01% 358
2017
Q2
$731K Buy
5,639
+69
+1% +$8.95K 0.01% 347
2017
Q1
$755K Buy
5,570
+151
+3% +$20.5K 0.02% 310
2016
Q4
$781K Buy
5,419
+2,069
+62% +$298K 0.02% 295
2016
Q3
$396K Sell
3,350
-75
-2% -$8.87K 0.01% 370
2016
Q2
$363K Buy
3,425
+780
+29% +$82.7K 0.01% 388
2016
Q1
$294K Hold
2,645
0.01% 404
2015
Q4
$414K Buy
2,645
+100
+4% +$15.7K 0.01% 353
2015
Q3
$334K Hold
2,545
0.01% 375
2015
Q2
$443K Sell
2,545
-30
-1% -$5.22K 0.01% 355
2015
Q1
$444K Hold
2,575
0.01% 362
2014
Q4
$334K Hold
2,575
0.01% 393
2014
Q3
$332K Hold
2,575
0.01% 378
2014
Q2
$228K Hold
2,575
0.01% 386
2014
Q1
$242K Sell
2,575
-38
-1% -$3.57K 0.01% 375
2013
Q4
$295K Buy
2,613
+38
+1% +$4.29K 0.01% 338
2013
Q3
$203K Buy
2,575
+275
+12% +$21.7K 0.01% 374
2013
Q2
$151K Buy
+2,300
New +$151K ﹤0.01% 387